These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27506290)

  • 1. Turning the respiratory flexibility of Mycobacterium tuberculosis against itself.
    Lamprecht DA; Finin PM; Rahman MA; Cumming BM; Russell SL; Jonnala SR; Adamson JH; Steyn AJ
    Nat Commun; 2016 Aug; 7():12393. PubMed ID: 27506290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid Bactericidal Activity Involves Electron Transport Chain Perturbation.
    Zeng S; Soetaert K; Ravon F; Vandeput M; Bald D; Kauffmann JM; Mathys V; Wattiez R; Fontaine V
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid.
    Kim S; Louie A; Drusano GL; Almoslem M; Kim S; Myrick J; Nole J; Duncanson B; Peloquin CA; Scanga CA; Yamada W; Neely M; Schmidt S
    Int J Antimicrob Agents; 2022 Feb; 59(2):106509. PubMed ID: 34958863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bedaquiline.
    Goulooze SC; Cohen AF; Rissmann R
    Br J Clin Pharmacol; 2015 Aug; 80(2):182-4. PubMed ID: 25702772
    [No Abstract]   [Full Text] [Related]  

  • 5. Clofazimine Exposure
    Ismail N; Peters RPH; Ismail NA; Omar SV
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.
    Xu J; Wang B; Hu M; Huo F; Guo S; Jing W; Nuermberger E; Lu Y
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis.
    Hartkoorn RC; Uplekar S; Cole ST
    Antimicrob Agents Chemother; 2014 May; 58(5):2979-81. PubMed ID: 24590481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis.
    Lechartier B; Cole ST
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4457-63. PubMed ID: 25987624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.
    Liu Y; Gao J; Du J; Shu W; Wang L; Wang Y; Xue Z; Li L; Xu S; Pang Y
    Int J Infect Dis; 2021 Jan; 102():392-396. PubMed ID: 33130209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline.
    Villellas C; Coeck N; Meehan CJ; Lounis N; de Jong B; Rigouts L; Andries K
    J Antimicrob Chemother; 2017 Mar; 72(3):684-690. PubMed ID: 28031270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
    Worley MV; Estrada SJ
    Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.
    Gupta S; Cohen KA; Winglee K; Maiga M; Diarra B; Bishai WR
    Antimicrob Agents Chemother; 2014; 58(1):574-6. PubMed ID: 24126586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants.
    Ismail N; Omar SV; Ismail NA; Peters RPH
    J Microbiol Methods; 2018 Oct; 153():1-9. PubMed ID: 30165087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon.
    Andres S; Merker M; Heyckendorf J; Kalsdorf B; Rumetshofer R; Indra A; Hofmann-Thiel S; Hoffmann H; Lange C; Niemann S; Maurer FP
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1564-1568. PubMed ID: 32053752
    [No Abstract]   [Full Text] [Related]  

  • 15. First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
    Kabahita JM; Kabugo J; Kakooza F; Adam I; Guido O; Byabajungu H; Namutebi J; Namaganda MM; Lutaaya P; Otim J; Kakembo FE; Kanyerezi S; Nabisubi P; Sserwadda I; Kasule GW; Nakato H; Musisi K; Oola D; Joloba ML; Mboowa G
    Antimicrob Resist Infect Control; 2022 May; 11(1):68. PubMed ID: 35550202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting the synthetic lethality between terminal respiratory oxidases to kill
    Kalia NP; Hasenoehrl EJ; Ab Rahman NB; Koh VH; Ang MLT; Sajorda DR; Hards K; Grüber G; Alonso S; Cook GM; Berney M; Pethe K
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7426-7431. PubMed ID: 28652330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TB47 and clofazimine form a highly synergistic sterilizing block in a second-line regimen for tuberculosis in mice.
    Yu W; Chiwala G; Gao Y; Liu Z; Sapkota S; Lu Z; Guo L; Khan SA; Zhong N; Zhang T
    Biomed Pharmacother; 2020 Nov; 131():110782. PubMed ID: 33152940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for
    Köser CU; Miotto P; Ismail N; Anthony RM; Utpatel C; Merker M; Niemann S; Tahseen S; Rigouts L; Rodrigues C; Omar SV; Farhat MR; Antonenka U; Hoffmann H; Cirillo DM; Schön T
    Eur Respir J; 2024 Jul; 64(1):. PubMed ID: 38991722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis.
    Berube BJ; Parish T
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
    Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L
    Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.